A Screening Study Targeting Tumor-specific Antigens

Clinical trial NCT05158621 · COMPLETED

Trial details

NCT number: NCT05158621
Sponsor: Gritstone bio, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Colorectal Cancer Stage II/III Colon Cancer

Start date: 2021-12-14
Primary completion: 2022-08-15
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.